Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
Armata Pharmaceuticals
ARMP
$173M
| $254K | ﹤0.01% |
107,066
+577
| +0.5% | +$1.48K |
|
3827
WidePoint Corp
WYY
$114M
| $253K | ﹤0.01% |
71,493
+1,475
| +2% | +$5.42K |
|
|
YARW
3828
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
| $253K | ﹤0.01% |
2,692
-21
| -0.8% | -$1.99K |
|
3829
Ark Restaurants
ARKR
$20.2M
| $251K | ﹤0.01% |
20,949
+7,017
| +50% | +$88.2K |
|
3830
Aqua Metals
AQMS
$10.2M
| $251K | ﹤0.01% |
6,707
+1,246
| +23% | +$65K |
|
|
LGVN
3831
Longeveron
LGVN
$24.2M
| $250K | ﹤0.01% |
128,947
+97,953
| +316% | +$250K |
|
3832
Dyadic International
DYAI
$36.4M
| $250K | ﹤0.01% |
240,175
+1,714
| +0.7% | +$2.29K |
|
3833
Battalion Oil
BATL
$28.8M
| $248K | ﹤0.01% |
37,205
+1,949
| +6% | +$7.32K |
|
3834
Data I/O
DAIO
$30.6M
| $248K | ﹤0.01% |
96,512
+22,804
| +31% | +$58.7K |
|
3835
Euroseas
ESEA
$531M
| $248K | ﹤0.01% |
+6,233
| New | +$214K |
|
|
AFCG
3836
AFC Gamma
AFCG
$63.4M
| $248K | ﹤0.01% |
24,225
+1,802
| +8% | +$17.4K |
|
3837
Usio Inc
USIO
$64M
| $248K | ﹤0.01% |
182,116
+9,731
| +6% | +$14.6K |
|
3838
Good Times Restaurants
GTIM
$15.5M
| $247K | ﹤0.01% |
90,947
+9,459
| +12% | +$26K |
|
3839
RenovoRx
RNXT
$50.5M
| $247K | ﹤0.01% |
232,937
+89,018
| +62% | +$99.7K |
|
3840
Grove Collaborative
GROV
$46.1M
| $246K | ﹤0.01% |
182,524
+9,114
| +5% | +$13K |
|
3841
Workhorse Group
WKHS
$36.3M
| $246K | ﹤0.01% |
1,888
+821
| +77% | +$139K |
|
3842
Intensity Therapeutics
INTS
$11.2M
| $246K | ﹤0.01% |
2,574
+669
| +35% | +$74.3K |
|
|
CMBM
3843
DELISTED
Cambium Networks
CMBM
| $246K | ﹤0.01% |
134,208
+3,083
| +2% | +$5.84K |
|
3844
Fortress Biotech
FBIO
$88.7M
| $244K | ﹤0.01% |
168,607
+37,736
| +29% | +$71.9K |
|
3845
Lipocine
LPCN
$17.6M
| $243K | ﹤0.01% |
54,216
+1,037
| +2% | +$5.21K |
|
3846
Endava
DAVA
$156M
| $243K | ﹤0.01% |
9,524
-2,451
| -20% | -$73.5K |
|
|
ANSC
3847
Agriculture & Natural Solutions Acquisition Corp
ANSC
$476M
| $242K | ﹤0.01% |
23,381
+5,599
| +31% | +$57.8K |
|
|
AZIO
3848
Azio AI Holdings
AZIO
$22.3M
| $241K | ﹤0.01% |
13,370
+1,006
| +8% | +$18.2K |
|
3849
IGC Pharma
IGC
$26.8M
| $240K | ﹤0.01% |
562,969
+133,142
| +31% | +$53.4K |
|
|
UBX
3850
DELISTED
Unity Biotechnology
UBX
| $240K | ﹤0.01% |
163,242
+14,199
| +10% | +$20.9K |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.